Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

China flag China · Delayed Price · Currency is CNY
23.01
-0.04 (-0.17%)
Mar 9, 2026, 4:00 PM EDT
15.63%
Market Cap 3.46B
Revenue (ttm) 510.33M
Net Income (ttm) 123.82M
Shares Out 150.34M
EPS (ttm) 0.82
PE Ratio 28.16
Forward PE n/a
Dividend 0.11 (0.50%)
Ex-Dividend Date May 20, 2025
Volume 2,167,520
Average Volume 1,316,290
Open 23.05
Previous Close 23.05
Day's Range 22.58 - 23.25
52-Week Range 15.70 - 27.95
Beta 0.79
RSI 44.25
Earnings Date Mar 27, 2026

About SHE:001367

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, sale, and import and export of pharmaceutical intermediates, active pharmaceutical ingredients, and preparations in China and internationally. The company offers active pharmaceutical ingredients for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, cardiovascular, antispasmodic, antibacterial agent, histamines drug, and anticonvulsant. It also provides chemical products for intermediates and food additives. Zhej... [Read more]

Sector Healthcare
Founded 1998
Employees 663
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 001367
Full Company Profile

Financial Performance

In 2024, SHE:001367's revenue was 471.51 million, an increase of 18.63% compared to the previous year's 397.45 million. Earnings were 122.56 million, an increase of 17.09%.

Financial Statements

News

There is no news available yet.